Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Potential therapeutic benefit of c1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat model.
MRI pattern in asymptomatic natalizumab-associated PML.
Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study.
[Effect of LINGO-1 gene silencing on movement function of EAE mice].
Urinary tract infections in multiple sclerosis.
Origins of oligodendrocytes in the cerebellum, whose development is controlled by the transcription factor, Sox9.
pERK1/2 Peripheral Recruitment and Filopodia Protrusion Augment Oligodendrocyte Progenitor Cell Migration: Combined Effects of PDGF-A and Fibronectin.
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.
Vitamin D as a protective factor in multiple sclerosis.
Additive effect of prostaglandin E(2) and adenosine in mouse experimental autoimmune encephalomyelitis.
Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Neuro-Behçet's disease, its mimickers and anti-TNF therapy: a case-based review.
AMP-Activated Protein Kinase Signaling Protects Oligodendrocytes that Restore Central Nervous System Functions in an Experimental Autoimmune Encephalomyelitis Model.
Efficacy of statins in combination with interferon therapy in multiple sclerosis: A meta-analysis.
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job).
Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 - 2014).
Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.
Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy.
Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis.
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
Response to IV immunoglobulin in a case of osmotic demyelination syndrome.
Correction: The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.
Central adaptation after optic neuritis: Is the whole greater than the sum of its parts?

Pages